t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia
- PMID: 10679918
t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia
Abstract
Until now, few data on additional chromosomal aberrations in t(11;14)-positive mantle cell lymphomas (MCLs) have been published. We analyzed 39 t(11;14)-positive MCLs by either comparative genomic hybridization (CGH; n = 8), fluorescence in situ hybridization (FISH) with a set of DNA probes detecting the most frequent aberrations in B-cell neoplasms (n = 12), or both techniques (n = 19). The t(11;14) was present in all cases. In 37 of 39 cases, chromosomal imbalances were found. In 27 cases, complex karyotypes, i.e., >/= 3 aberrations, were identified. The most frequent aberrations were losses of 13q14-21 or 13q32-34 (27 cases), 9p21 (16 cases), and 11q22-23 (12 cases) and gains of 3q26-29 (19 cases), 8q22-24 (11 cases), and 18q21-22 (9 cases). In 26% of cases (7 of 27) analyzed by CGH, a total of 10 high-level DNA amplifications were identified. Although in comparison with B-cell chronic lymphopcytic leukemia (B-CLL) MCL is characterized by a much higher complexity of chromosomal aberrations, there are striking similarities: 13q14 deletions were identified in more than 50% of both MCL and B-CLL cases. In contrast, in our CGH database containing 293 B-cell lymphomas, this aberration was found in only 11% of other nodal lymphomas. Even more strikingly, 11q deletions, which are present in 20%-30 % of MCL and B-CLL, were found very rarely in other nodal B-cell lymphomas (CGH: 1 of 208 cases; FISH: 1 of 69 cases). These data show that MCL is characterized by specific secondary aberrations and that there may be similarities in the pathogenesis of MCL and B-CLL. Genes Chromosomes Cancer 27:285-294, 2000.
Copyright 2000 Wiley-Liss, Inc.
Similar articles
-
Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.Genes Chromosomes Cancer. 2008 Dec;47(12):1086-97. doi: 10.1002/gcc.20609. Genes Chromosomes Cancer. 2008. PMID: 18709664
-
Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation.Cancer Res. 1997 Mar 15;57(6):1144-50. Cancer Res. 1997. PMID: 9067285
-
Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH.Br J Haematol. 2007 Apr;137(2):117-24. doi: 10.1111/j.1365-2141.2007.06526.x. Br J Haematol. 2007. PMID: 17391491
-
B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia.Br J Haematol. 2004 May;125(3):330-6. doi: 10.1111/j.1365-2141.2004.04913.x. Br J Haematol. 2004. PMID: 15086413 Review.
-
Genetics of small lymphocyte disorders.Semin Hematol. 1999 Apr;36(2):171-7. Semin Hematol. 1999. PMID: 10319386 Review.
Cited by
-
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.J Clin Oncol. 2007 Apr 1;25(10):1216-22. doi: 10.1200/JCO.2006.08.4251. Epub 2007 Feb 12. J Clin Oncol. 2007. PMID: 17296973 Free PMC article.
-
The prognostic significance of 13q deletions of different sizes in patients with B-cell chronic lymphoproliferative disorders: a retrospective study.Int J Hematol. 2017 Sep;106(3):418-425. doi: 10.1007/s12185-017-2240-2. Epub 2017 Apr 24. Int J Hematol. 2017. PMID: 28439775
-
Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome).Am J Pathol. 2002 Sep;161(3):957-68. doi: 10.1016/S0002-9440(10)64256-3. Am J Pathol. 2002. PMID: 12213724 Free PMC article.
-
Impact of Genetics on Mature Lymphoid Leukemias and Lymphomas.Cold Spring Harb Perspect Med. 2020 Nov 2;10(11):a035444. doi: 10.1101/cshperspect.a035444. Cold Spring Harb Perspect Med. 2020. PMID: 31932467 Free PMC article. Review.
-
The Therapeutic Synergy of Selinexor and Venetoclax in Mantle Cell Lymphoma Through Induction of DNA Damage and Perturbation of the DNA Damage Response.Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231208608. doi: 10.1177/15330338231208608. Technol Cancer Res Treat. 2023. PMID: 37880950 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources